Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To compare Invasive Disease-Free Survival (IDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant chemotherapy with 1 year of bevacizumab.
Inclusion criteria
- Early primary invasive adenocarcinoma of the breast (triple negative and/or basal-like phenotype)